Purchase an iCare® HOME2 today for as low as $106/mo. Pay over time with flexible financing options!

We’ve partnered with Affirm® to offer flexible and affordable financing options. Check to see if you qualify at checkout—checking eligibility won’t affect your credit. ​

Publications & Press Releases

iCare HOME tonometry reliably detects IOP changes in Glaucoma.

MyEYES strives to continually keep our patients updated as to the latest information regarding Glaucoma. This article from the American Academy of Ophthalmology highlights the reliability and effectiveness of the iCare HOME tonometer. – C S Epperson, MyEYES.

Conclusion from the article:

“…This study demonstrates the utility of home tonometry with the iCare HOME device as a reliable tool for detecting therapy-related changes in IOP response from medical and laser treatments outside of clinical settings. Home monitoring also provides additional valuable information regarding treatment effects on intraday and interday fluctuations via the increased number of IOP measurements, which may help clinicians to better treat patients who have significant IOP fluctuations and not overtreat those who may show no treatment effect on office-based GAT measurement…”

This original article was available online at AAO April 1, 2022

Facebook
Twitter
LinkedIn
Pinterest
MyEYES, LLC

MyEYES, LLC

Our mission is to make it easier to get home tonometers into hands of the people who need it. In this way, IOP data collected over the span of a week or two at several time points during the day and or night can help to direct an individual patients’ doctors to provide the ideal treatment for that patient’s tailored need. The result: the most effective way to proactively slow the damaging and blinding progression of this horrible disease.

Leave a Reply

Your email address will not be published. Required fields are marked *